John K. Chan, MD
Director, Gynecologic Oncology
UCSF Helen Diller Comprehensive Cancer Center
1600 Divisadero St., Box 1702
San Francisco,
CA
USA
94143
Papers:
75 - Focused Plenary
The economic impact associated with caring for the morbidly obese with endometrial cancer: a nationwide study of 6,560 women
116 - Featured Poster
Disparities in the use of robotic surgery in endometrial cancer based on race and socioeconomic status in the United States
136 - Scientific Plenary
A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 m
139 - Scientific Plenary
Health-related quality of life associated with every-3-week paclitaxel vs dose-dense weekly paclitaxel in combination with carboplatin with or without bevacizumab for primary ovarian cancer: Gynecologic Oncology Group study 262
363 - Poster Session B
Trends in robotic surgery in uterine cancer: a nationwide study of 13,719 patients
378 - Poster Session B
Type I uterine cancer in United States (US)-born vs immigrants: a study of 4,834 patients
379 - Poster Session B
The use of a geographic information system to identify advanced cervical cancer patients in California
384 - Poster Session B
The increase in type I uterine cancer in 9,217 Hispanic women: a 20-year study
423 - Poster Session B
The characterization of morbidly obese ovarian cancer patients in the United States: a study of demographic and socioeconomic status
454 - Poster Session B
Trends in the pathological diagnosis of serous fallopian tube, peritoneal, and ovarian cancer in the US
Faculty
Late Breaking Abstract 2
A phase II study to determine the response to second curettage as initial management for persistent "low-risk" non-metastatic gestational trophoblastic neoplasia: A Gynecologic Oncology Group study